In 2023, the antidepressant medicine sales in Australia stood at 382.5 Million US Dollars PPP. The forecasted data indicates a steady growth in sales from 2024 to 2028. Year-on-year, the sales are expected to increase by 0.9% in 2024, 0.85% in 2025, 0.8% in 2026, 0.71% in 2027, and 0.68% in 2028. Over the last two years, the compound annual growth rate (CAGR) is anticipated to be approximately 0.79% per year.
Looking ahead, the following trends are worth noting:
- Advancement in pharmaceutical technology and the introduction of new, effective drugs.
- Increasing awareness and diagnosis of mental health conditions.
- Growing acceptance and reduction of stigma associated with mental health treatment.
- Potential influence of government policy on drug pricing and healthcare funding.
